Brookline Capital Acquisition Corp.

NasdaqCM:BCAC Stock Report

Market Cap: US$144.0m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Brookline Capital Acquisition Management

Management criteria checks 1/4

Key information

Sam Wertheimer

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.2yrs
CEO ownershipn/a
Management average tenure2.2yrs
Board average tenure1.4yrs

Recent management updates

Recent updates

CEO

Sam Wertheimer

2.2yrs

Tenure

Dr. Samuel P. Wertheimer, also known as Sam, has served as Executive Vice President of Poliwogg Regenerative Medicine Fund, Inc. and is currently Chief Investment Officer and a Managing Director of Poliwog...

Leadership Team

NamePositionTenureCompensationOwnership
Samuel Wertheimer
Chairman & CEO2.2yrsno datano data
Scott Katzmann
President & Director2.2yrsno datano data
Patrick Sturgeon
Chief Financial Officer2.2yrsno datano data

2.2yrs

Average Tenure

Experienced Management: BCAC's management team is considered experienced (2.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Samuel Wertheimer
Chairman & CEO2.2yrsno datano data
Scott Katzmann
President & Director1.4yrsno datano data
James Hauslein
Independent Director1.4yrsno datano data
Tito Serafini
Independent Director1.4yrsno datano data
Elgar Peerschke
Independent Director1.4yrsno datano data

1.4yrs

Average Tenure

64yo

Average Age

Experienced Board: BCAC's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.